Sumimasa Arimura, Ph.D.
Picture
Sumimasa Arimura, Ph.D.
Instructor
Positions
- Instructor
-
Medicine-Gastroenterology
Baylor College of Medicine
Houston, TX US
Education
- BS from Showa Pharmaceutical University
- 03/2002 - Tokyo, Japan
- MS from Showa Pharmaceutical University
- 03/2004 - Tokyo, Japan
- PhD from Kyoto University
- 07/2009 - Kyoto, Japan
- Postdoctoral Fellowship at Kyoto University
- 08/2009 - Kyoto, Japan
- Postdoctoral Fellowship at The University of Tokyo, Assistant Professor at The University of Tokyo
- 01/2018 - Tokyo, Japan
- Research Fellowship at Baylor College of Medicine
- 12/2019 - Houston, United States
Certifications
- Pharmacist (Japan)
Professional Statement
I promote innovative technology development and applied research aimed at Cell Therapies (Stem Cell Regulated Therapy, Cell Differentiation Therapy, Cell Transplantation Therapy, and Remote Cell Therapy).Selected Publications
- Arimura S, To S, Mills JC "Changing fate: how EGFRs "pit" cell vs cell in the stomach." Gastroenterology. 2024;167:441-442.
- Adkins-Threats M*, Arimura S* and Mills JC, et. al. (*Co-1st. authors) "Metabolic regulator ERRγ governs stem cell differentiation into acid-secreting parietal cells." Cell Stem Cell. 2024;31:886-903.
- Arimura S and Yamanashi Y, et. al. "Loss of Dok-3 in non-tumor cells induces malignant conversion of benign epithelial tumors of the intestine." Cancer Research Communications. 2022;2:1590-600.
- Arimura S and Yamanashi Y, et. al. "DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction." Science. 2014;345:1505-8.
- Mashima R*, Arimura S* and Yamanashi Y, et. al. (*Co-1st. authors) "Dok adaptors play anti-inflammatory roles in pulmonary homeostasis." Genes to Cells. 2013;1:56-65.
- Arimura S and Taketo MM., et. al. "Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling." Gastroenterology. 2009;137:629-38.
Projects
- - Creating Functional Cells and Therapeutic Applications -
- 1. Developing technology to analyze gastrointestinal physiology
- 2. Developing innovative technologies to treat advanced cancers
- 3. Developing gastrointestinal cell replacement technology
- 4. Developing cellular remote-control technology
Funding
- 2023-2027: NIDDK R01 grant : Co-I (PI: Jason C. Mills) - #R01 DK094989-12 NIH/NIDDK
- 2021-2022: The Texas Medical Center Digestive Diseases Center (TMC-DDC) Pilot/Feasibility Award: PI - #P30DK056338 NIH/NIDDK
- 2018-2019: Research in A Foreign Country (A special 2-year adopter): PI - #201640201 The Uehara Memorial Foundation (Japan)
- 2018-2018: Medical and Pharmaceutical Research in A Foreign Country: PI - #2017R1-1 Mochida Memorial Foundation (Japan)
- 2015-2017: Grant-in-Aid for Encouragement of Young Scientists A: PI - #15H05574 ( Japan Society for the Promotion of Science: JSPS)
- 2014-2017: The Practical Research Project for Rare/Intractable Diseases: Co-I - #16ek0109003h0003 ( Japan Agency for Medical Research and Development: AMED)
- 2010-2013: Grant-in-Aid for JSPS Fellow Research: PI - #10J08500 ( Japan Society for the Promotion of Science: JSPS)
Languages
Japanese
Log In to edit your profile
